Research

July 10, 2024 – AlphaRank Factor Performance represents the daily historical performance of Accelerate’s proprietary model factor portfolios. (more…)

June 25, 2024 - In last month's Merger Monitor, Hipster Antitrust, we discussed the FTC's aggressive approach to antitrust regulations. We concluded that its actions have thus far not resulted in a demonstrably higher deal termination rate nor longer average deal timelines (at least not yet). So far,…

June 23, 2024 - Stock market breadth, which analyzes the number of stocks advancing versus the number of stocks declining, is a time-tested stock market tool that helps gauge investor sentiment and parse emerging risks. Breadth indicators help investors understand the participation level of stocks in market movements…

June 7, 2024 – AlphaRank Factor Performance represents the daily historical performance of Accelerate’s proprietary model factor portfolios. (more…)

May 28, 2024 - Hipster Antitrust is a novel antitrust philosophy that challenges the traditional consumer welfare standard, which has historically relied on rational price theory analysis. This contemporary antitrust movement seeks to go above and beyond by addressing broader societal concerns stemming from the potential…

May 25, 2024 - Spring showers bring May... disinflation? Given the above-average performance of equities year-to-date, holders of risk assets have pinned their hopes on the decline in the inflation rate to continue until it gradually reaches the Federal Reserve's 2% target. While the jury's still…

May 10, 2024 – AlphaRank Factor Performance represents the daily historical performance of Accelerate’s proprietary model factor portfolios. (more…)

April 29, 2024 - What began as a robust merger market, with North American M&A deal announcements averaging twenty per month in the first quarter of this year, slowed to a snail's pace in April, with just nine transactions struck in a spring slowdown. Despite a choppy equity market, steadily rising…

April 6, 2024 – AlphaRank Factor Performance represents the daily historical performance of Accelerate’s proprietary model factor portfolios. (more…)

March 31, 2024 - The pharmaceutical industry is constantly under pressure to innovate and develop new medicines to address society's unmet medical needs and to satiate Wall Street's demand for earnings growth and continued profitability. One of the major challenges facing large pharmaceutical companies is the expiration of patents on…